$NOVO B (-7,73%)
$NVO (-7,33%)

Next entry 45

$NVO (-7,33%)
$NOVO B (-7,73%)

Second entry, next 55 + -

$NOVO B (-7,73%)
$NVO (-7,33%)

First entry

So I just realised that I've been investing for exactly 1 year and 1 week, so I thought this would be a good moment to reflect. I'm 36, the total portfolio size is 50k+ and the money isn't needed in short term. My portfolio summarised:

1. ETF core, 50% at minimum: $VDEV (+0,63%) and $VFEM (+1,98%) , recently added $EUE (+0,85%) as I see more potential in the EU than in the US in the short-medium term. I like how a combination of these 3 ETFs allows for more adaptability than simply putting everything in a world ETF. Plus, the TER is a bit lower.

2. Individual stocks, max 10 positions, only including companies that I understand and have faith in that they will perform well in the next couple of years. The goal is to at least match $IWDA (+0,74%) but preferably to make some additional gains. In summary:

Tech:

$NVDA (-1,35%) : committed after the post-Deepseek dip, will just wait out all the short-term turbulence

$AMZN (-0,36%) : doesn't need additional info.

$ASML (+0,02%) : ditto

$VRT (+2,11%) : see one of my previous posts on GQ. Bit too volatile for me now, but when the AI-hype picks up again, will perform well.

Health:

$NVO (-7,33%) : I have a lot of faith in the GLP1-narrative, stock is very undervalued

$LLY (+14,61%) : same at NVO, got pummeled hard recently but in longer term another good bet in the GLP1-race.

Divident:

$ALV (+0,81%) : popular German insurance company. Divident-wise, I have more faith in insurance companies than banks. Banks also face more headwinds due to fintech.

$ASRNL (+0%) : comparable to Allianz, solid, no-nonsense Dutch insurance company.

Bit more speculative:

$NU (+2,52%) : I think fintech has a lot of potential and NU was valued quite cheaply compared to US- or EU-based counterparts. Could benefit from US recession if USD evaluates.

What are your thoughts? What would you add or lose? I'm thinking of adding $GOOG (-1,33%) when the current downtrend subsides. Does make the portfolio more tech-heavy but all companies are internationally oriented (in case of US recession) and should outperform in the longer term.

Thanks in advance!

Today S&P reached an important support level and I started my buy strategy.

After that I bought back some $TROW (+1,15%) shares, $NVO (-7,33%) and $ENI (+1,55%)

And I was thinking to add to my portfolio one of those, $GOOG (-1,33%)
$META (+0,27%) or $MSFT (-0,72%) wich one would you choose?

$NVO (-7,33%)

🔹 Q4 Revenue: DKK 85.68B (Est. DKK 80.29B) 🟢

🔹 Q4 Wegovy Sales: DKK 19.9B; More than doubled YoY

🔹 FY Revenue: DKK 290.40B (Est. DKK 285.57B) 🟢; UP +25% YoY

🔹 FY EBIT: DKK 128.34B (Est. DKK 125.96B) 🟢

Regional Breakdown:

🔹 North America Revenue: UP +30% YoY

🔹 International Operations Revenue: UP +17% YoY

Q4 Operating Metrics:

🔹 Operating Profit: DKK 36.7B (Est. DKK 33.6B) 🟢; UP +37% YoY

FY'25 Outlook:

🔹 Sales Growth: 16%-24% at CER

🔹 Operating Profit Growth: 19%-27% at CER

🔹 Sales and profit growth in DKK expected to be 3pp and 5pp higher than CER

Operational & Strategic Updates:

🔸 Completed acquisition of three Catalent manufacturing sites

🔸 R&D Progress: CagriSema and Semaglutide trials show superior weight loss efficacy

🔸 Dividend: Board to propose DKK 7.90/share final dividend (Total 2024 dividend: DKK 11.40/share, UP +21% YoY)

CEO Lars Fruergaard Jørgensen's Commentary:

🔸 "Strong 2024 performance with 26% sales growth, benefiting over 45M people globally. Focus remains on commercial execution, expanding R&D pipeline, and scaling production capacity in 2025."